Glooko, Inc. Overview
Pro stress-test →Glooko, Inc. is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. The company is uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings.
Strategic Profile
Pro stress-test →Glooko's suite of software solutions includes the Glooko diabetes management platform, EndoTool® Glucose Management System, Glooko XT, and the Glooko Mobile App, reflecting the company's focus on simplifying diabetes and glycemic management for healthcare providers, hospitals and health systems, and people living with diabetes. In May 2026, Glooko was selected as the winner of the "Best Overall MedTech Software" award in the 10th annual MedTech Breakthrough Awards program.
Competitive Landscape
Pro stress-test →Glooko competes in the diabetes and glycemic management software space alongside vendors including Wellframe, Health2Sync, Apree Health, and GlySens. The company differentiates through a comprehensive software portfolio spanning remote patient monitoring, inpatient glucose management, and mobile engagement, plus clinical leadership and integration of acquired assets like Monarch Medical Technologies.
Industry Context
Glooko, Inc. operates in Diabetes management digital health software.
Key facts
Founded: Unknown · Headquarters: Palo Alto, US · Employees: Unknown · Revenue: Not publicly available · Market cap: N/A